Cargando…
Characterization of Different Subtypes of Immune Cell Infiltration in Glioblastoma to Aid Immunotherapy
Glioblastoma multiforme (GBM) has been identified as a frequently occurring adult primary brain cancer that is highly aggressive. Currently, the prognostic outcome for GBM patients is dismal, even with intensive treatment, and the median overall survival (OS) is 14.6 months. Immunotherapy, which is...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254719/ https://www.ncbi.nlm.nih.gov/pubmed/35799789 http://dx.doi.org/10.3389/fimmu.2022.799509 |